← Back to Screener
Tectonic Therapeutic, Inc. Common Stock (TECX)
Price$29.00
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)27.34%
Price vs S&P 500 (4W)0.01%
VGM Score62.50
Market Capitalization$547.21M
All Metrics
Book Value / Share (Quarterly)$12.24
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-3.48
Price vs S&P 500 (YTD)30.86%
EPS (TTM)$-4.46
10-Day Avg Trading Volume0.18M
EPS Excl Extra (TTM)$-4.46
EPS (Annual)$-4.05
ROI (Annual)-29.46%
Cash / Share (Quarterly)$12.58
ROA (Last FY)-28.41%
EBITD / Share (TTM)$-4.92
Cash Flow / Share (Annual)$-3.22
P/B Ratio2.37x
P/B Ratio (Quarterly)2.52x
Net Income / Employee (Annual)$-1,235,800
Net Interest Coverage (TTM)-9.38x
ROA (TTM)-30.92%
EPS Incl Extra (Annual)$-4.05
Current Ratio (Annual)26.63x
Quick Ratio (Quarterly)18.28x
3-Month Avg Trading Volume0.32M
52-Week Price Return29.18%
Revenue / Employee (TTM)$0
52-Week High$36.03
EPS Excl Extra (Annual)$-4.05
26-Week Price Return35.26%
Quick Ratio (Annual)26.32x
13-Week Price Return4.13%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)18.51x
Enterprise Value$310.59M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$13.54
3-Month Return Std Dev78.28%
Net Income / Employee (TTM)$-1,391,400
ROE (Last FY)-29.50%
EPS Basic Excl Extra (Annual)$-4.05
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-4.46
ROI (TTM)-32.27%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)4.81%
Year-to-Date Return39.02%
5-Day Price Return0.38%
EPS Normalized (Annual)$-4.05
ROA (5Y Avg)-54.07%
Month-to-Date Return-6.95%
EBITD / Share (Annual)$-4.53
LT Debt / Equity (Annual)0.44x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-4.46
P/B Ratio (Annual)1.55x
Book Value / Share (Annual)$13.41
Price vs S&P 500 (13W)-4.13%
Beta1.31x
Revenue / Share (TTM)$0.00
ROE (TTM)-32.33%
52-Week Low$14.39
mGradeB
vgmGradeB
Show chart for
Earnings Surprise History
Q1 26-1.34est. -1.21
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.20
4.20
4.25
4.31
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TECXTectonic Therapeutic, Inc. Common Stock | — | — | B | $29.00 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
Tectonic Therapeutics is a biotechnology company discovering and developing therapeutic proteins and antibodies that modulate GPCR function. Using its proprietary GEODe platform, the company designs biologic medicines to treat serious diseases with limited or no existing therapeutic options. The pipeline includes TX2100, a GPCR antagonist for hereditary hemorrhagic telangiectasia and fibrosis, and a program for pulmonary hypertension.